ATTD: Advanced Technologies and Treatments for Diabetes

In this episode of ATTD Diabetes Talks, host Diana Isaacs is joined by Dr. Medha Munshi, Director of the Joslin Geriatric Diabetes Program and Professor of Medicine at Harvard Medical School. Together, they discuss the science behind weekly insulin, patient selection criteria, tailoring therapy to individual needs, and specific considerations for older or medically complex adults. Key Takeaways: C...

In this episode, we explore the science behind weekly insulin, including the pharmacology of weekly insulin, its mechanism of action, how it differs from daily insulin formulations, and why it provides consistent control over a longer period. Guest: Dr. Manasi Shah, Assistant Professor of Medicine at Eastern Virginia Medical School and Director of the Inpatient Diabetes Program at Sentara Norfolk...

In this inaugural episode of ATTD Diabetes Talks: The Power of Weekly Insulin , we delve into the evolution and future of basal insulin therapy. Host Diana Isaacs sits down with Dr. Rodolfo Galindo to explore the pharmacological innovations behind weekly insulin formulations and discuss how this breakthrough is reshaping modern diabetes management. Guest: Dr. Rodolfo Galindo (Associate Professor o...

Join host Dr. David Ahn and guest Dr. Michael Haller (Professor and Chief of Pediatric Endocrinology at the University of Florida and Chair of TrialNet) as they take a comprehensive review of the evidence base and remaining gaps for inhaled insulin use in pediatric and adolescent populations In this final episode, we dive into: Key Challenges in Pediatrics: Unmet needs in pediatric insulin therapy...

Join host Dr. David Ahn and guest Dr. Roy Beck (Founder and Medical Director of the Jaeb Center for Health Research) as they explore the integration of inhaled insulin with automated insulin delivery (AID) systems. In this episode, we dive into: The potential of combining inhaled insulin with current AID technologies. Theoretical advantages, including postprandial management. Current evidence, cli...

In this episode, we examine the concept of "therapeutic inertia" in diabetes care. Dr. David Ahn is joined by Dr. Grazia Aleppo, Professor of Medicine at the Feinberg School of Medicine, Northwestern University, to explore how inhaled insulin can help address the clinical and behavioral barriers often associated with insulin initiation. Key discussion points: Defining therapeutic inertia in the co...

In our new series, The Role of Inhaled Insulin, host Dr David Ahn looks at the practical implementation of inhaled insulin in clinical practice. He is joined by Dr Irl Hirsch. They discuss: Where inhaled insulin fits today within the overall insulin therapy landscape The best candidates for inhaled insulin in routine clinical practice Key clinical factors to guide decision-making Practical first s...

In today’s episode, Dr Bob Gabbay is joined by Dr Elena Toschi to address the most common questions clinicians have when it comes to insulin therapy. They discuss: The most common mistakes or misconceptions in basal insulin initiation and management Intensification strategies such as titration, adding prandial insulin, or using fixed-ratio combinations Leveraging technologies to improve insulin ad...

In today’s episode, Dr Bob Gabbay is joined by Dr Anne Peters to discuss personalized insulin approaches for complex populations. They discuss: Why personalization is particularly important in insulin therapy The patient groups most in need of a tailored approach How comorbidities or frailty influence insulin decision-making Guidelines, flexibility, and local solutions Dr Peters is a Professor of...

In this episode, host Bob Gabbay and his guest, Diana Isaacs PharmD, break down common barriers to insulin adherence; from the common reasons people may struggle with insulin, to behaviour change approaches that can help clinicians support their patients. They discuss: The barriers most misunderstood by clinicians Communication and motivational interviewing with patients Emotional burden and fear...

In this episode, host Bob Gabbay and his guest, Professor Simon Heller, discuss preventing and managing hypoglycemia, with a focus on the risks, recognition, and safety education. They discuss: Why hypoglycemia remains a major concern in insulin therapy Key risk factors to keep in mind Clinical signs or patient-reported symptoms Prevention strategies Importance of patient education Balancing glyce...

In this episode, host Bob Gabbay and his guest, Professor Tadej Battelino, Co-Chair of ATTD, discuss the latest technological innovations in diabetes, including delivery innovations, connected devices, titration support. They discuss: The new technologies making the biggest difference in insulin therapy today The role of smart pens, connected devices, and apps Biggest clinical impact - including a...

In this episode, host Bob Gabbay and his guest, Dr George Grunberger, Chairman of the Grunberger Diabetes Institute, discuss best practice and guidance around basal insulin and GLP-1 combinations. They discuss: What exactly fixed-ratio combinations are and the problems they tackle Identifying patient candidates and timelines for starting FRCs Meaningful benefits of FRCs compared with basal insulin...

In this episode, host Bob Gabbay and his guest, Dr William Polonsky discuss safe and effective titration strategies, and the importance of collaborating with your patient. They discuss: The importance of titration in successful insulin therapy Barriers to titration, including patient self-management How clinicians can collaborate with patients in their titration journey The importance of language...

In this episode, host Bob Gabbay and his guest, Dr Osama Hamdy, discuss how clinicians can identify patients for insulin initiation in Type 2 diabetes. They discuss: When clinicians should consider insulin for patients with T2D Addressing concerns of weight gain with insulin ADA/EASD recommendations Barriers to insulin therapy and Type 2 diabetes Advice on communication with patients Dr Osama Hamd...

In our new series, Insulin in Practice, host Dr Bob Gabbay looks at the principles of Basal Insulin Therapy in Type 2 Diabetes; its physiological role, pharmacodynamics, and current guideline-based use. He is joined by Dr Giulio Romeo. They discuss: The role of basal insulin in normal physiology and why it matters in Type 2 diabetes Goals of basal insulin therapy What makes new basal insulins diff...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  Advancements in Type 1 Diabetes: From Pathogenesis to Therapy , featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies.  Join us as we summarize key takeaways from these thought-provoking presentations:  Role of Viruses in Pathogenesis of Type 1 Diabetes  –...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care , where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use.  Join us as we summarize key takeaways from these thought-provoking presentations:  Welcome &amp...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  Continuous Glucose Monitoring (CGM) Outside the Traditional Areas , exploring innovative applications of CGM beyond its conventional use in diabetes management.  Join us as we summarize key takeaways from these thought-provoking presentations:  CGM As a Guide to Lifestyle and Weight Management  –  Dr. Nicola Guess   CGM in Non-diabe...

In this episode of ATTD 2026 Conference Catch-Up, we dive into  Cardiovascular Disease in Type 1 Diabetes , featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes.  While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular bu...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  Refining Care of Type 1 Diabetes , featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes.  Join us as we summarize key takeaways from these thought-provoking presentations:  Refining Care of Type 1 Diabetes  –  Dr. Lori Laffel   Improving Glycemic Contro...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  Managing Overweight & Obesity in Type 1 Diabetes , featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes.  As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond gl...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  Adjunct Therapies with Automated Insulin Delivery , featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes.  As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 dia...

In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year.  Join us as we summarize key takeaways from these thought-provoking presentations:  •  Continuous and Intermittent Glucose Monitoring  –  Professor Jen...

In this episode of  ATTD 2026 Conference Catch-Up , we dive into  Debate: HbA1c and Not CGM Should Be the Gold Standard to Evaluate Glucose Control , featuring a dynamic exchange of perspectives on the most accurate method for assessing glucose control in diabetes.  Join us as we summarize key takeaways from these thought-provoking presentations:  Pro  –  Dr. Elizabeth Selvin   Con  –  Dr. Richard...